Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Markers of the Course of Covid-19 Based on Biomarker Serum Amyloid A (SAA) and Genetic Markers

NCT07120269 is registered in ClinicalTrials.gov with Thomayer University Hospital as lead sponsor.

NCT NCT07120269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07120269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Markers of the Course of Covid-19 Based on Biomarker Serum Amyloid A (SAA) and Genetic Markers
Lead sponsor
Thomayer University Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 10, 2021
Completion date
December 31, 2026
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19